NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Revenue

NovaBay Pharmaceuticals had revenue of $14.23M in the twelve months ending March 31, 2024, with 5.66% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.63M with 12.48% year-over-year growth. In the year 2023, NovaBay Pharmaceuticals had annual revenue of $14.73M with 2.24% growth.

• Revenue (ttm): $14.23M
• Revenue Growth: +5.66%
• P/S Ratio: 0.16
• Revenue / Employee: $593,042
• Employees: 24
• Market Cap: 2.35M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.73M	322.00K	2.24%
Dec 31, 2022	14.40M	4.20M	41.16%
Dec 31, 2021	10.20M	270.00K	2.72%
Dec 31, 2020	9.93M	3.34M	50.54%
Dec 31, 2019	6.60M	-5.91M	-47.24%
Dec 31, 2018	12.51M	-5.72M	-31.39%
Dec 31, 2017	18.23M	6.33M	53.23%
Dec 31, 2016	11.90M	7.52M	171.56%
Dec 31, 2015	4.38M	3.33M	315.65%
Dec 31, 2014	1.05M	-2.42M	-69.69%
Dec 31, 2013	3.48M	-3.47M	-49.95%
Dec 31, 2012	6.95M	-4.07M	-36.95%
Dec 31, 2011	11.02M	1.27M	12.97%
Dec 31, 2010	9.75M	-5.93M	-37.81%
Dec 31, 2009	15.68M	8.96M	133.32%
Dec 31, 2008	6.72M	809.00K	13.68%
Dec 31, 2007	5.91M	4.38M	285.71%
Dec 31, 2006	1.53M	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.